AI Article Synopsis
- First case report highlights the successful use of nab-paclitaxel in treating patients who experienced severe hypersensitivity reactions to paclitaxel and docetaxel.
- The study shows that nab-paclitaxel can be a safe alternative for patients who cannot handle traditional taxane chemotherapies.
- This finding could open new treatment avenues for those suffering from severe side effects of common cancer drugs.
Article Abstract
•First case report of successfully treating severe paclitaxel and docetaxel hypersensitivity reaction with nab-paclitaxel•We demonstrated that nab-paclitaxel is a safe taxane chemotherapy treatment option for patients who could not tolerate paclitaxel or docetaxel.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3862232 | PMC |
| http://dx.doi.org/10.1016/j.gynor.2013.05.003 | DOI Listing |
Publication Analysis
Top Keywords
paclitaxel docetaxel
12
hypersensitivity reaction
8
successful treatment
4
treatment nab-paclitaxel
4
nab-paclitaxel hypersensitivity
4
reaction paclitaxel
4
docetaxel •first
4
•first case
4
case report
4
report treating
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!